보고서 요약(국문)

개요
글로벌 천식 스페이서 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
흡입기 스페이서, 홀딩 챔버, 천식 스페이서는 모두 천식과 같은 호흡기 질환 치료에 사용되는 의료 기기입니다. 이러한 기기들은 정량식 흡입기(MDI)를 사용하여 약물이 폐로 흡입되는 방식을 개선하기 위해 만들어졌습니다. 천식 스페이서는 환자가 처방된 약물을 모두 복용하도록 하여 부작용 위험을 줄이고 치료 효과를 높이는 데 필수적입니다.
천식 스페이서 시장은 천식, 만성 폐쇄성 폐질환(COPD), 기관지염과 같은 호흡기 질환의 유병률 증가에 따라 크게 영향을 받았습니다. 이러한 질환이 더욱 확산됨에 따라 효율적인 호흡기 약물 전달 방법, 특히 스페이서에 대한 수요가 증가했습니다.

천식 스페이서 사용의 이점은 이제 환자와 의료진 모두에게 더 잘 이해되고 있습니다. 스페이서는 폐로의 약물 전달 효율을 높여 부작용 발생 가능성을 최소화하고 환자가 처방된 약물을 전량 복용할 수 있도록 보장합니다.
시장 동향: 주요 동인
천식 유병률 증가
천식은 폐의 기도에 염증을 일으키는 만성 호흡기 질환입니다. 란셋(Lancet)에 따르면 2020년 전 세계 천식 환자 수는 3억 3,900만 명으로 증가 추세에 있습니다. 천식은 모든 연령대에서 발생할 수 있지만, 어린이가 성인보다 발병률이 높습니다. 천식의 정확한 원인은 알려져 있지 않지만 유전적 요인과 환경적 요인이 복합적으로 작용하는 것으로 여겨집니다. 천식의 일반적인 증상으로는 쌕쌕거림, 기침, 가슴 답답함, 호흡 곤란 등이 있습니다.

글로벌 천식 네트워크(Global Asthma Network)에서 작성한 2022년 세계 천식 보고서에 따르면 인도에서는 약 3,500만 명이 천식을 앓고 있습니다. 보고서에 따르면 인도에서 천식 퇴치를 가로막는 주요 장애물은 진단 부족과 불충분한 치료입니다. 또한 인도에서는 상당수의 어린이가 천식을 앓고 있습니다. 천식 관리를 위한 개입은 지역 사회 교육과 1차 의료 수준에서 필요한 의약품 및 물품의 우선 공급에서 시작되어야 합니다.
천식 치료에는 제로스탯 VT 스페이서 투명 흡입기 스페이서가 사용됩니다. 이 제품은 고품질 소재로 제작되어 오랫동안 사용할 수 있습니다. 제로스탯 VT 스페이서 투명 흡입기 스페이서는 천식 환자 치료에 사용되는 약물 전달 시스템으로, 에어로졸화 방식을 사용하는 흡입기입니다.
인식 및 교육 부족
천식 스페이서 사용의 이점에 대한 인식 부족과 올바른 사용법에 대한 환자 교육 부족은 시장 확대를 저해할 수 있습니다. 흡입기와 함께 스페이서를 사용하는 이점에 대해 많은 환자와 의료 전문가들이 충분히 이해하지 못하고 있을 수 있습니다. 비용은 천식 스페이서 사용에 있어 주요 장애물이 될 수 있습니다. 특히 보험이 없거나 정기적으로 교체해야 하는 경우, 이러한 장치는 일부 환자에게 부담이 될 수 있습니다. 일부 환자는 스페이서가 있는 정량식 흡입기(MDI)보다 네뷸라이저나 건조 분말 흡입기(DPI)를 선호할 수 있습니다. 천식 스페이서에 대한 수요는 개인의 선호도와 특정 장치 사용에 대한 편안함 정도에 따라 다를 수 있습니다.
세그먼트 분석
전 세계 천식 스페이서 시장은 유형, 유통 채널 및 지역별로 세분화됩니다.
에어로챔버 부문은 시장 점유율의 약 45.6%를 차지했습니다.
에어로챔버는 천식, 만성 폐쇄성 폐질환(COPD) 또는 기타 호흡기 질환 환자의 호흡을 용이하게 하기 위해 개발된 최첨단 의료 기기입니다. 에어로챔버는 약물 분무액이 환자에게 도달하도록 하는 플라스틱 튜브, 얼굴을 덮는 마스크 또는 앞쪽에 있는 마우스피스, 그리고 경우에 따라 투여되는 약물을 덮는 플라스틱 커버가 뒤쪽에 부착된 형태로 구성됩니다.
연령대에 따라 다양한 모델의 에어로챔버가 제공됩니다. 일부 제조업체는 1~6세 어린이용과 6세 이상 성인용처럼 연령대별로 별도의 모델을 선택하는 반면, 다른 제조업체는 분리 가능한 에어로챔버 마스크가 있는 단일 에어로챔버를 사용합니다.
바이오시넥스 에어로챔버는 유아용, 어린이용, 성인용으로 제공되며 라텍스와 비스페놀 A가 함유되지 않은 제품입니다. 에어로챔버는 효과적인 호흡기 질환 치료에 필수적인 요소입니다. 바이오시넥스 에어로챔버는 계량 흡입기를 사용하여 약물을 투여하기 어려운 모든 연령대의 사람들을 위해 설계되었습니다.
지리적 시장 침투
천식 유병률 증가 및 선진 의료 인프라
북미는 전 세계 천식 스페이서 시장에서 지배적인 위치를 차지하고 있습니다. 거주 지역은 천식에 큰 영향을 미칩니다. 천식 환자는 저렴하고 질 높은 의료 서비스, 깨끗한 공기, 안정적인 경제 상황에 접근할 수 있을 때 질환을 관리하고 치료할 가능성이 더 높습니다.
2023년 4월, 미국 폐 협회는 4,190만 명의 미국인이 천식 진단을 받은 적이 있다고 추산했습니다. 천식은 기도에 영향을 미치는 만성 질환입니다. 흉통, 기침, 천명음 등의 증상이 나타났다 사라지기를 반복합니다. 천식은 모든 연령대에 영향을 미치지만, 주로 어린이에게서 발생합니다.
마우스피스에 일방향 밸브가 있는 스페이서의 한 종류는 밸브식 약물 저장실입니다. 이러한 장치는 입과 약물 사이에 단순히 "공간"을 제공하는 것 이상의 기능을 합니다. 약물을 저장하고 가두어 환자가 잠시 숨을 깊게 내쉴 수 있도록 해줍니다. 이를 통해 약물을 완전히 흡입할 수 있습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업에 전례 없는 어려움을 초래했습니다. 천식과 같은 기존 호흡기 질환을 가진 사람들은 팬데믹으로 인해 건강에 대한 인식이 높아졌고, 호흡기 건강의 중요성이 부각되었습니다. 이러한 인식 제고로 인해 천식용 스페이서 및 기타 호흡 보조 기기에 대한 수요가 증가했을 가능성이 있습니다.
원격 진료와 원격 모니터링은 많은 의료 서비스 제공자들이 코로나19 노출 위험을 줄이기 위해 활용한 두 가지 전략입니다. 화상 상담을 통해 천식 및 기타 호흡기 질환 환자들은 기기 사용 및 관리 방법에 대한 조언을 받았을 수 있으며, 이는 스페이서 사용 증가로 이어졌을 수 있습니다.

제품 유형별
• 에어로챔버
• 옵티챔버
• 볼루매틱
• 인스파이어레이즈
유통 채널별
• 소매 약국
• 병원 약국
• 전자상거래
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Cipla Inc, Koninklijke Philips N.V., Déposition Pulmonaire des Médicaments SAS, Monaghan Medical Corporation, Truedell Medical International, Duomed, PARI GmbH, Laboratoire ProtecSom 및 Haag-streit 그룹 등이 있습니다.

보고서 구매 이유
• 유형, 유통 채널, 지역별 글로벌 천식 스페이서 시장 세분화를 시각화하고 주요 상업 자산 및 업체들을 파악하기 위해
• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴하기 위해
• 모든 세그먼트를 포함한 천식 스페이서 시장 수준의 다양한 데이터가 담긴 엑셀 시트 제공
• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서 제공

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 엑셀 파일 제공

글로벌 천식 스페이서 시장 보고서는 약 46개의 표, 53개의 그림, 186페이지 분량으로 구성됩니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The Global Asthma Spacers Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
Inhaler spacers, holding chambers, and asthma spacers are all medical devices used to treat respiratory disorders like asthma. They are made to enhance the way medication is inhaled into the lungs using metered-dose inhalers (MDIs). Asthma spacers are essential in ensuring that patients take their prescription medication in its entirety, lowering the risk of side effects, and enhancing the overall efficacy of treatment.
The market for asthma spacers has been significantly impacted by the rising prevalence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. The need for efficient respiratory medicine delivery methods, particularly spacers, has increased as these illnesses become more widespread.
The advantages of employing asthma spacers are now better understood by patients and healthcare practitioners. Spacers increase the effectiveness of drug delivery to the lungs, minimizing the chance of adverse effects and guaranteeing that patients receive the entire quantity of their prescription medications.
Market Dynamics: Drivers
The Increasing Prevalence of Asthma
A chronic respiratory condition called asthma enlarges and inflames the lungs' airways. As per the Lancet, the asthma statistics worldwide for 2020 reported that the number of persons with asthma, a total of 339 million worldwide, is rising. Although asthma can afflict people of any age, children are more likely than adults to get the condition. Although the exact cause of asthma is unknown, it is thought to be a result of both hereditary and environmental factors. Wheezing, coughing, chest tightness, and shortness of breath are all typical signs of asthma.
The Global Asthma Report 2022, prepared by Global Asthma Network, shows that Asthma affects roughly 35 million people in India. According to the report, underdiagnosis and insufficient treatment are significant obstacles to the fight against asthma in India. Asthma also affects a significant portion of children in India. Interventions for controlling asthma must start with community education and the prioritization of required drugs and supplies at the primary healthcare level.
For the treatment of asthma, the Zerostat VT Spacer Transparent inhaler space is intended. This item is made of high-quality materials and will last you for a very long time. A drug delivery system called a Zerostat VT Spacer Transparent Inhaler Space is used to treat asthma patients. It is an inhaler that employs the aerosolization method of operation.
Lack of Awareness and Education
Lack of knowledge regarding the advantages of employing asthma spacers and insufficient patient education on their proper use can impede market expansion. The benefits of utilizing spacers with inhalers may not be fully understood by many patients and healthcare professionals. Cost can be a major obstacle to the use of asthma spacers. These devices might be costly for some patients, especially if they do not have insurance or if they have to replace them regularly. Nebulizers and dry powder inhalers (DPIs) may be preferred by some patients over MDIs with spacers. Demand for asthma spacers may vary depending on individual preferences and level of comfort using particular devices.
Segment Analysis
The global asthma spacers market is segmented based on type, distribution channel and region.
The aerochambers segment accounted for approximately 45.6% of the market share
Aerochambers are cutting-edge medical tools made to make it easier for people with asthma, COPD, or other respiratory disorders to breathe. Aerochambers are made up of a plastic tube that allows the drug spray to reach the patient, a mask that goes over the face or a mouthpiece on the front, and sometimes a plastic cover for the medication that is being administered that is attached to the back.
Depending on the age range, different models of aerochambers are available. Some manufacturers opt for a distinct model for each age range, such as one for children aged 1-6 and another for those above the age of 6, while others use a single aerochamber with a detachable aerochamber mask.
Biosynex Aerochambers come in infant, child, and adult sizes and are assured to be latex and bisphenol A-free. They are a crucial component of effective respiratory disease treatment. Biosynex aerochambers are designed for people of all ages who still find it difficult to take the medication with a metered dose inhaler.
Geographical Penetration
The Increasing Prevalence of Ashma and Advanced Healthcare Infrastructure
North America has been a dominant force in the global asthma spacers market. Where a person lives has a big impact on their asthma. People with asthma have a better chance of managing and treating their condition if they have access to inexpensive, quality healthcare, clean air, and stable economic conditions.
In April 2023, the American Lung Association estimates that 41.9 million Americans have ever had an asthma diagnosis. A persistent illness that affects the airways is asthma. Chest pain, coughing, and wheezing are some symptoms that can come and go. All ages are affected by asthma; however, it most often develops in children.
One sort of spacer that has a one-way valve at the mouthpiece is a valved holding chamber. More than just "space" between the mouth and the medication is provided by these devices. Additionally, it holds and traps medication, allowing patients to take a moment to exhale deeply. This makes it possible to inhale the complete pharmaceutical dose.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide. People with pre-existing respiratory illnesses, such as asthma, became more aware of their health as a result of the pandemic, which brought to light the significance of respiratory health. The demand for asthma spacers and other breathing devices may have increased as a result of the greater awareness.
Telemedicine and remote monitoring are two strategies that many healthcare providers have used to lower the danger of exposure to COVID-19. Through virtual consultations, patients with asthma and other respiratory disorders may have received advice on how to use and manage devices, thereby increasing the adoption of spacers.
By Product Type
• Aerochamber
• Optichamber
• Volumatic
• Inspirease
By Distribution Channel
• Retail Pharmacy
• Hospital Pharmacy
• E-Commerce
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Cipla Inc, Koninklijke Philips N.V., Déposition Pulmonaire des Médicaments SAS, Monaghan Medical Corporation, Truedell Medical International, Duomed, PARI GmbH, Laboratoire ProtecSom and Haag-streit group among others.
Why Purchase the Report
• To visualize the global asthma spacers market segmentation based on type, distribution channel, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of asthma spacers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global asthma spacers market report would provide approximately 46 tables, 53 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Distribution Channel
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Prevalence of Asthma
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. Lack of Awareness and Education
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Aerochamber*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Optichamber
7.4. Volumatic
7.5. Inspirease
8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Retail Pharmacy*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospital Pharmacy
8.4. E-Commerce
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Cipla Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Koninklijke Philips N.V.
11.3. Déposition Pulmonaire des Médicaments SAS
11.4. Monaghan Medical Corporation
11.5. Duomed
11.6. Others
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Cipla Inc., 4.	Key Developments, Koninklijke Philips N.V., Déposition Pulmonaire des Médicaments SAS, Monaghan Medical Corporation, Duomed, Others

표 목록 (Tables)

List of Tables Table 1 Global Asthma Spacers Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Asthma Spacers Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Asthma Spacers Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Asthma Spacers Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Asthma Spacers Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 7 Global Asthma Spacers Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)

Table 8 Global Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 9 Global Asthma Spacers Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 10 Global Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 11 Global Asthma Spacers Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 12 Global Asthma Spacers Market Value, By Region, 2022-2033 (US$ Billion)

Table 13 North America Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 14 North America Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 15 North America Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 16 North America Asthma Spacers Market Value, By Country, 2022-2033 (US$ Billion)

Table 17 Europe Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 18 Europe Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 19 Europe Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 20 Europe Asthma Spacers Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Asthma Spacers Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 South America Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 26 South America Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 27 South America Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 28 South America Asthma Spacers Market Value, By Country, 2022-2033 (US$ Billion)

Table 29 Middle East and Africa Asthma Spacers Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 30 Middle East and Africa Asthma Spacers Market Value, By Material, 2022-2033 (US$ Billion)

Table 31 Middle East and Africa Asthma Spacers Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 32 Middle East and Africa Asthma Spacers Market Value, By Country, 2022-2033 (US$ Billion)

Table 33 Monaghan Medical Corp.: Overview

Table 34 Monaghan Medical Corp.: Product Portfolio

Table 35 Monaghan Medical Corp.: Key Developments

Table 36 Flexicare (Group) Limited: Overview

Table 37 Flexicare (Group) Limited: Product Portfolio

Table 38 Flexicare (Group) Limited: Key Developments

Table 39 Koninklijke Philips N.V.,: Overview

Table 40 Koninklijke Philips N.V.,: Product Portfolio

Table 41 Koninklijke Philips N.V.,: Key Developments

Table 42 Space Chamber: Overview

Table 43 Space Chamber: Product Portfolio

Table 44 Space Chamber: Key Developments

Table 45 Rossmax International Ltd: Overview

Table 46 Rossmax International Ltd: Product Portfolio

Table 47 Rossmax International Ltd: Key Developments

Table 48 Trudell Medical International Inc.: Overview

Table 49 Trudell Medical International Inc.: Product Portfolio

Table 50 Trudell Medical International Inc.: Key Developments

Table 51 Able Healthcare: Overview

Table 52 Able Healthcare: Product Portfolio

Table 53 Able Healthcare: Key Developments

Table 54 Medline Industries, LP.: Overview

Table 55 Medline Industries, LP.: Product Portfolio

Table 56 Medline Industries, LP.: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 4 Global Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 5 Global Asthma Spacers Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Asthma Spacers Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 7 Aerochamber Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 8 Optichamber Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 9 Volumatic Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 10 Inspirease Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 11 Others Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 12 Global Asthma Spacers Market Y-o-Y Growth, By Material, 2023-2033 (%)

Figure 13 Polycarbonate Material in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 14 Acrylonitrile Butadiene Styrene Material in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 15 Polypropylene Material in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 16 Others Material in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 17 Global Asthma Spacers Market Y-o-Y Growth, By Distribution Channel, 2023-2033 (%)

Figure 18 Hospital Pharmacies Distribution Channel in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 19 Retail Pharmacies Distribution Channel in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 20 Online Pharmacies Distribution Channel in Global Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 21 Global Asthma Spacers Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 22 North America Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 23 North America Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 24 North America Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 25 North America Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 26 North America Asthma Spacers Market Share, By Country, 2024 & 2033 (%)

Figure 27 Europe Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 28 Europe Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 29 Europe Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 30 Europe Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 31 Europe Asthma Spacers Market Share, By Country, 2024 & 2033 (%)

Figure 32 Asia-Pacific Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 33 Asia-Pacific Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 34 Asia-Pacific Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 35 Asia-Pacific Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 36 Asia-Pacific Asthma Spacers Market Share, By Country, 2024 & 2033 (%)

Figure 37 South America Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 38 South America Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 39 South America Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 40 South America Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 41 South America Asthma Spacers Market Share, By Country, 2024 & 2033 (%)

Figure 42 Middle East and Africa Asthma Spacers Market Value, 2022-2033 (US$ Billion)

Figure 43 Middle East and Africa Asthma Spacers Market Share, By Product Type, 2024 & 2033 (%)

Figure 44 Middle East and Africa Asthma Spacers Market Share, By Material, 2024 & 2033 (%)

Figure 45 Middle East and Africa Asthma Spacers Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 46 Monaghan Medical Corp.: Financials

Figure 47 Flexicare (Group) Limited: Financials

Figure 48 Koninklijke Philips N.V., Financials

Figure 49 Space Chamber: Financials

Figure 50 Rossmax International Ltd: Financials

Figure 51 Trudell Medical International Inc.: Financials

Figure 52 Able Healthcare: Financials

Figure 53 Medline Industries, LP.: Financials

세계 천식용 스페이서 시장 – 2023-2030

Global Asthma Spacers Market - 2023-2030